OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Appraising the “entourage effect”: Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer
Sandra Blasco-Benito, Marta Seijo-Vila, Miriam Caro-Villalobos, et al.
Biochemical Pharmacology (2018) Vol. 157, pp. 285-293
Closed Access | Times Cited: 166

Showing 51-75 of 166 citing articles:

In the weeds: A comprehensive review of cannabis; its chemical complexity, biosynthesis, and healing abilities
Fatima-Zahrae Laaboudi, Mohamed Rejdali, Hassan Amhamdi, et al.
Toxicology Reports (2024) Vol. 13, pp. 101685-101685
Open Access | Times Cited: 4

Validated quantitative cannabis profiling for Canadian regulatory compliance - Cannabinoids, aflatoxins, and terpenes
Alistair K. Brown, Zhe Xia, Patrique Bulloch, et al.
Analytica Chimica Acta (2019) Vol. 1088, pp. 79-88
Closed Access | Times Cited: 35

Antitumor Cannabinoid Chemotypes: Structural Insights
Paula Morales, Nadine Jagerovic
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 31

An effective drug sensitizing agent increases gefitinib treatment by down regulating PI3K/Akt/mTOR pathway and up regulating autophagy in non-small cell lung cancer
Jue Zhang, Zhipeng Qu, Hong Yao, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 118, pp. 109169-109169
Open Access | Times Cited: 31

Promoting cannabis products to pharmaceutical drugs
Hinanit Koltai, Patrick Poulin, Dvory Namdar
European Journal of Pharmaceutical Sciences (2019) Vol. 132, pp. 118-120
Closed Access | Times Cited: 30

Chronological Review and Rational and Future Prospects of Cannabis-Based Drug Development
Dvora Namdar, Omer Anis, Patrick Poulin, et al.
Molecules (2020) Vol. 25, Iss. 20, pp. 4821-4821
Open Access | Times Cited: 30

Cancer Initiation, Progression and Resistance: Are Phytocannabinoids from Cannabis sativa L. Promising Compounds?
Ersilia Nigro, Marialuisa Formato, Giuseppina Crescente, et al.
Molecules (2021) Vol. 26, Iss. 9, pp. 2668-2668
Open Access | Times Cited: 27

The Pathophysiology and the Therapeutic Potential of Cannabinoids in Prostate Cancer
Kanika Singh, Nazim Nassar, Ava Bachari, et al.
Cancers (2021) Vol. 13, Iss. 16, pp. 4107-4107
Open Access | Times Cited: 26

Antimicrobial and Antiviral (SARS-CoV-2) Potential of Cannabinoids and Cannabis sativa: A Comprehensive Review
Md Sultan Mahmud, Mohammad Sorowar Hossain, A T M Faiz Ahmed, et al.
Molecules (2021) Vol. 26, Iss. 23, pp. 7216-7216
Open Access | Times Cited: 26

Secondary Terpenes in Cannabis sativa L.: Synthesis and Synergy
Francisco T. Chacon, Wesley M. Raup‐Konsavage, Kent E. Vrana, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3142-3142
Open Access | Times Cited: 18

Does the “Entourage Effect” in Cannabinoids Exist? A Narrative Scoping Review
João Luís Q. Simei, José Diogo R. Souza, João Roberto Lisboa, et al.
Cannabis and Cannabinoid Research (2023) Vol. 9, Iss. 5, pp. 1202-1216
Closed Access | Times Cited: 10

Cannabinoids and standardized cannabis extracts inhibit migration, invasion, and induce apoptosis in MCF-7 cells through FAK/MAPK/Akt/NF-κB signaling
Wiwit Suttithumsatid, Wanida Sukketsiri, Pharkphoom Panichayupakaranant
Toxicology in Vitro (2023) Vol. 93, pp. 105667-105667
Closed Access | Times Cited: 10

Cannabis sativa L. Extract Increases COX-1, COX-2 and TNF-α in the Hippocampus of Rats with Neuropathic Pain
Joanna Bartkowiak-Wieczorek, Małgorzata Jamka, Radosław Kujawski, et al.
Molecules (2025) Vol. 30, Iss. 1, pp. 194-194
Open Access

Acute and prolonged toxicity assessment of Cannabis sativa extract in rodents and lagomorphs
Alana C. Costa, Arquimedes Gasparotto, Alana Anne Kaneda Garcia, et al.
Toxicology Reports (2025), pp. 101918-101918
Open Access

Cannabinoids as Promising Inhibitors of HER2-Tyrosine Kinase: A Novel Strategy for Targeting HER2-Positive Ovarian Cancer
Thomanai Lamtha, Nathjanan Jongkon, Tossaporn Lertvanithphol, et al.
ACS Omega (2025) Vol. 10, Iss. 6, pp. 6191-6200
Open Access

Development of Gas-Chromatographic Method for Simultaneous Determination of Cannabinoids and Terpenes in Hemp
Jure Zekič, Mitja Križman
Molecules (2020) Vol. 25, Iss. 24, pp. 5872-5872
Open Access | Times Cited: 26

Assessment of Cannabidiol and Δ9-Tetrahydrocannabiol in Mouse Models of Medulloblastoma and Ependymoma
Clara Andradas, Jacob Byrne, Mani Kuchibhotla, et al.
Cancers (2021) Vol. 13, Iss. 2, pp. 330-330
Open Access | Times Cited: 23

(−)-trans9-Tetrahydrocannabiphorol Content of Cannabis sativa Inflorescence from Various Chemotypes
Justin Bueno, Eric A. Greenbaum
Journal of Natural Products (2021) Vol. 84, Iss. 2, pp. 531-536
Closed Access | Times Cited: 23

Psychedelics for Brain Injury: A Mini-Review
M. Ijaz Khan, Gregory T. Carter, Sunil Aggarwal, et al.
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 22

Analysis of Anti-Cancer and Anti-Inflammatory Properties of 25 High-THC Cannabis Extracts
Dongping Li, Yaroslav Ilnytskyy, Esmaeel Ghasemi Gojani, et al.
Molecules (2022) Vol. 27, Iss. 18, pp. 6057-6057
Open Access | Times Cited: 15

Cannabis Roots: Therapeutic, Biotechnological and Environmental Aspects
Valérie Gagné, Nathalie Boucher, Isabel Desgagné‐Penix
Cannabis and Cannabinoid Research (2024) Vol. 9, Iss. 1, pp. 35-48
Closed Access | Times Cited: 3

Cannabidiol as a novel therapeutic agent in breast cancer: evidence from literature
Mojtaba Esmaeli, Maryam Dehghanpour Dehabadi, Ali Asghar Khaleghi
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access

Scroll to top